StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII – Free Report) to a sell rating in a research note published on Thursday morning. 22nd Century Group Price Performance Shares of NASDAQ:XXII opened at $1.24 on Thursday. 22nd Century Group has a twelve month low of $1.23 and a twelve month high of $164.40. The stock […]
StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII – Free Report) to a sell rating in a research report report published on Friday morning. 22nd Century Group Price Performance Shares of XXII opened at $1.40 on Friday. The company has a quick ratio of 0.43, a current ratio of 0.54 and a debt-to-equity ratio of […]
StockNews.com upgraded shares of 22nd Century Group (NASDAQ:XXII – Free Report) to a sell rating in a research note published on Friday. 22nd Century Group Price Performance XXII stock opened at $1.39 on Friday. The stock has a 50-day moving average price of $11.74 and a two-hundred day moving average price of $39.56. 22nd Century […]
Several analysts have recently updated their ratings and price targets for 22nd Century Group (NASDAQ: XXII): 8/23/2023 – 22nd Century Group had its “buy” rating reaffirmed by analysts at Roth Mkm. They now have a $5.00 price target on the stock. 8/17/2023 – 22nd Century Group was downgraded by analysts at Alliance Global Partners from […]
22nd Century Group (NASDAQ:XXII – Get Free Report) had its price objective dropped by investment analysts at Dawson James from $10.00 to $7.50 in a research report issued to clients and investors on Tuesday, Marketbeat reports. The brokerage currently has a “buy” rating on the biotechnology company’s stock. Dawson James’ price target suggests a potential […]